Effect of trans10, cis12-conjugated linoleic acid on glucose consumption of insulin resistance chang liver cells

Journal of Food Biochemistry

Volumn 35, Issue 6, 2011, Pages 1593-1602

  Li, Chengcheng ^a   Wang, Jihui ^a   Wang, Han ^a   Cai, Shijie ^b   Mu, Guangqing ^a   Zou, Wei ^c   Zhang, Xiaojuan ^a   Tian, Lili ^a   Chen, Hongzhou ^a  

^a DALIAN POLYTECHNIC UNIVERSITY   (China)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c LIAONING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENEFICIAL EFFECTS; BIOLOGICALLY ACTIVE COMPOUNDS; CONJUGATED LINOLEIC ACID; DOSE-DEPENDENT; FUNCTIONAL FOODS; GLUCOSE CONSUMPTION; GLUCOSE UPTAKE; INSULIN RESISTANCE; INSULIN SIGNALING; KEY CHARACTERISTICS; LIVER CELLS; LY294002; PHOSPHATIDYLINOSITOL 3-KINASE; POTENTIAL EFFECTS; PROTEIN LEVEL; RESEARCH AND DEVELOPMENT; TYPE-2 DIABETES;

BIOACTIVITY; CELLS; ENZYMES; GLUCOSE; INSULIN; ISOMERS; UNSATURATED FATTY ACIDS;

LINOLEIC ACID;

EID: 83055184316     PISSN: 01458884     EISSN: 17454514     Source Type: Journal    
DOI: 10.1111/j.1745-4514.2010.00485.x     Document Type: Article

References (45)

1. BHATTACHARYA, A., BANU, J., RAHMAN, M., CAUSEY, J. and FERNANDES, G. 2006. Biological effects of conjugated linoleic acids in health and disease (reviews). J. Nutr. Biochem. 17, 789-781.
2. CHO, H.J., KIM, W.K., KIM, E.J., JUNG, K.C., PARK, S., LEE, H.S., TYNER, A.L. and PARK, J.H.Y. 2003. Conjugated linoleic acid inhibits cell proliferation and ErbB3 signaling in HT-29 human colon cell line. Am. J. Physiol. Gastrointest. Liver Physiol. 284(6), 996-1005.
3. CHOI, J.S., JUNG, M.H., PARK, H.S. and SONG, J. 2004. Effect of conjugated linoleic acid isomers on insulin resistance and mRNA levels of genes regulating energy metabolism in high-fat-fed rats. Nutrition 20(11-12), 1008-1017.
4. CHOI, J.S., KOH, I.U., JUNG, M.H. and SONG, J. 2007. Effects of three different conjugated linoleic acid preparations on insulin signalling, fat oxidation and mitochondrial function in rats fed a high-fat diet. Br. J. Nutr. 98(2), 264-275.
5. CHUNG, S., BROWN, J.M., PROVO, J.N., HOPKINS, R. and MCINTOSH, M.K. 2005. Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. J. Biol. Chem. 280(46), 38445-38456.
6. CUSI, K., MAEZONO, K., OSMAN, A., PENDERGRASS, M., PATTI, M.E., PRATIPANAWATR, T., DEFRONZO, R.A., KAHN, C.R. and MANDARINO, L.J. 2000. Insulin resistance differentially affects the PI3-kinase and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105(3), 311-320.
7. DUE, A., LARSEN, T.M., HERMANSEN, K., STENDER, S., HOLST, J.J., TOUBRO, S., MARTINUSSEN, T. and ASTRUP, A. 2008. Comparison of the effects on insulin resistance and glucose tolerance of 6-month high-monounsaturated-fat, low-fat, and control diets. Am. J. Clin. Nutr. 87, 855-862.
8. EYJOLFSON, V., SPRIET, L.L. and DYCK, D.J. 2004. Conjugated linoleic acid improves insulin sensitivity in young, sedentary humans. Med. Sci. Sports Exerc. 36(5), 814-820.
9. FRITSCHE, J.R.R. and STEINHART, H. 1999. Formation, contents, and estimation of daily intake of conjugated linoleic acid isomers and trans-fatty acids in foods. Adv. Conjugated Linoleic Acid Res. 1, 378-396.
10. GAO, D., GRIFFITHS, H.R. and BAILEY, C.J. 2009. Oleate protects against palmitate-induced insulin resistance in L6 myotubes. Br. J. Nutr. 22, 1-7.
11. GARG, A. 1998. High-monounsaturated-fat diets for patients with diabetes mellitus: A meta-analysis. Am. J. Clin. Nutr. 67, 577-582.
12. GAULLIER, J.M., HALSE, J., HOYE, K., KRISTIANSEN, K., FAGERTUN, H., VIK, H. and GUDMUNDSEN, O. 2004. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am. J. Clin. Nutr. 79, 1118-1125.
13. GUAL, P., LE MARCHAND-BRUSTEL, Y. and TANTI, J.F. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87(1), 99-109.
14. HENRIKSEN, E.J., TEACHEY, M.K., TAYLOR, Z.C., JACOB, S., PTOCK, A., KRAMER, K. and HASSELWANDER, O. 2003. Isomer-specific actions of conjugated linoleic acid on muscle glucose transport on the obese Zucker rat. Am. J. Physiol. 285, 93-105.
15. HOUSEKNECHT, K.L., VANDEN HEUVEL, J.P., MOYA-CAMARENA, S.Y., PORTOCARRERO, C.P., PECK, L.W., NICKEL, K.P. and BELURY, M.A. 1998. Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty fa/fa rat. Biochem. Biophys. Res. Commun. 244(3), 678-682.
16. IWAKIRI, Y., SAMPSON, D.A. and ALLEN, K.G. 2002. Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Prostaglandins Leukot. Essent. Fatty Acids 67(6), 435-443.
17. JEFFREY, E., PESSIN, J.E. and ALAN, R. 2000. Signaling pathways insulin action: Molecular targets of insulin resistance. J. Clin. Invest. 106, 165-169.
18. JIN, U.H., KANG, Y.J., CHANG, Y.C. and KIM, C.H. 2008. Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells. J. Cell. Biochem. 103(3), 908-919.
19. KARLSSON, H.K. and ZIERATH, J.R. 2007. Insulin signaling and glucose transport in insulin resistant human skeletal muscle. Cell Biochem. Biophys. 48(2-3), 103-113.
20. LIN, H., BOYLSTON, T.D., CHANG, M.J., LUEDECKE, L.O. and SHULTZ, T.D. 1995. Survey of the conjugated linoleic acid contents of dairy products. J. Dairy Sci. 78(11), 2358-2365.
21. LOWELL, B.B. and SHULMAN, G.I. 2005. Mitochondrial dysfunction and type 2 diabetes. Science 307(5708), 384-387.
22. LUONGO, D., BERGAMO, P. and ROSSI, M. 2003. Effects of conjugated linoleic acid on growth and cytokine expression in Jurkat T cells. Immunol. Lett. 90, 195-201.
23. NAGAO, K., INOUE, N., WANG, Y.M. and YANAGITA, T. 2003. Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa/fa) rats. Biochem. Biophys. Res. Commun. 310, 562-566.
24. OCHOA, J.J., FARQUHARSON, A.J., GRANT, I., MOFFAT, L.E., HEYS, S.D. and WAHLE, K.W. 2004. Conjugated linoleic acids (CLAs) decrease prostate cancer cell proliferation: Different molecular mechanisms for cis-9, trans-11 and trans-10, cis-12 isomers. Carcinogenesis 25(7), 1185-1191.
25. PARIZA, M.W. and HARGRAVES, W.A. 1985. A beef-derived mutagenesis modulator inhibits initiation of mouse epidermal tumors by 7, 12-dimethylben-z[a]anthracene. Carcinogenesis 6, 591-593.
26. PARK, Y., ALBRIGHT, K.J., LIU, W., STORKSON, J.M., COOK, M.E. and PARIZA, M.W. 1997. Effect of conjugated linoleic acid on body composition in mice. Lipids 32, 853-858.
27. PARODI, P.W. 1997. Cows' milk fat components as potential anticarcinogenic agents. J. Nutr. 127(6), 1055-1060.
28. POIRIER, H., ROUAULT, C., CLEMENT, L., MONNOT, M.C., GUERREMILLO, M. and BESNARD, P. 2005. Hyperinsulinaemia triggered by dietary conjugated linoleic acid is associated with a decrease in leptin and adiponectin plasma levels and pancreatic beta cell hyperplasia in the mouse. Diabetologia 48, 1059-1065.
29. POIRIER, H., SHAPIRO, J.S., KIM, R.J. and LAZAR, M.A. 2006. Nutritional supplementation with trans-10, cis-12-conjugated linoleic acid induces inflammation of white adipose tissue. Diabetes 55(6), 1634-1641.
30. RAINER, L. and HEISS, C.J. 2004. Conjugated linoleic acid: Health implications and effects on body composition. J. Am. Diet. Assoc. 104, 963-968.
31. RISÉRUS, U., ARNER, P., BRISMAR, K. and VESSBY, B. 2002. Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 25(9), 1516-1521.
32. RISÉRUS, U., VESSBY, B., ARNLOV, J. and BASU, S. 2004. Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation and proinflammatry markers in obese men. Am. J. Clin. Nutr. 80, 279-283.
33. ROCHE, H.M., NOONE, E., SEWTER, C., MC BENNETT, S., SAVAGE, D., GIBNEY, M.J., ORAHILLY, S. and VIDAL-PUIG, A.J. 2002. Isomer-dependent metabolic effects of conjugated linoleic acid: Insights from molecular markers sterol regulatory element-binding protein-1c and LXRalpha. Diabetes 51, 2037-2044.
34. ROS, E. 2003. Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am. J. Clin. Nutr. 78(3), 617-625.
35. RYDER, J.W., PORTOCARRERO, C.P., SONG, X.M., CUI, L., YU, M., COMBATSIARIS, T., GALUSKA, D., BAUMAN, D.E., BARBANO, D.M., CHARRON, M.J. ET AL. 2001. Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression. Diabetes 50(5), 1149-1157.
36. SHULTZ, T.D., CHEW, B.P., SEAMAN, W.R. and LUEDECKE, L.O. 1992. Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells. Cancer Lett. 63(2), 125-133.
37. TANIGUCHI, C.M., KONDO, T., SAJAN, M., LUO, J., BRONSON, R., ASANO, T., FARESE, R., CANTLEY, L.C. and KAHN, C.R. 2005. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta. Cell Metab. 3(5), 343-353.
38. TRICON, S., BURDGE, G.C., KEW, S., BANERJEE, T., RUSSELL, J.J., JONES, E.L., GRIMBLE, R.F., WILLIAMS, C.M., YAQOOB, P. and CALDER, P.C. 2004. Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am. J. Clin. Nutr. (80), 614-620.
39. TSUBOYAMA-KASAOKA, N., TAKAHASHI, M., TANEMURA, K., KIM, H.J., TANGE, T., OKUYAMA, H., KASAI, M., IKEMOTO, S. and EZAKI, O. 2000. Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 49, 1534-1542.
40. VISTICA, D.T., SKEHAN, P. and SCUDIERO, D. 1991. Tetrazolium-based assays for cellular viability: A critical examination of selected parameters affecting formazan production. Cancer Res. 51(10), 2515-2520.
41. WANG, Y. and JONES, P.J. 2004. Dietary conjugated linoleic acid and body composition. Am, J, Clin, Nutr. 79, 1153S-1158S.
42. WARGENT, E., SENNITT, M.V., STOCKER, C., MAYES, A.E., BROWN, L., O'DOWD, J., WANG, S., EINERHAND, A.W.C, MOHEDE, I., ARCH, J.R.S. ET AL. 2005. Prolonged treatment of genetically obese mice with conjugated linoleic acid improves glucose tolerance and lowers plasma insulin concentration: Possible involvement of PPAR activation. Lipids Health Dis. 4, 3.
43. XIE, W., WANG, W., SU, H., XING, D., PAN, Y. and DU, L. 2006. Effect of ethanolic extracts of Ananas comosus L. leaves on insulin sensitivity in rats and HepG2. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 143(4), 429-435.
44. YANG, M. and COOK, M.E. 2003. Dietary conjugated linoleic acid decreased cachexia, macrophage tumor necrosis factor-alpha production, and modifies splenocyte cytokines production. Exp. Biol. Med. 228, 51-58.
45. ZIMMET, P., ALBERTI, K.G. and SHAW, J. 2001. Global and societal implications of the diabetes epidemic. Nature 414(6865), 782-787.